Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases
European Journal of Internal Medicine · 2025-01 · 131 · 3-14
DOI: 10.1016/j.ejim.2024.08.026 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Journal of Internal Medicine, 2025-01. Verfasst von Yuting Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, PR China. Hauptthemen laut MEDLINE: Biomarkers, Blood Glucose, Triglycerides, Insulin Resistance. Die Arbeit wurde bisher 284-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The Triglyceride-glucose index (TyG index) is a comprehensive statistical measure that incorporates fasting triglyceride and fasting glucose levels. Research has demonstrated that it can serve as an effective alternative biomarker for insulin resistance (IR) due to its high sensitivity and specificity. The TyG index is straightforward to compute and imposes fewer time and cost constraints, rendering it suitable for large populations and advantageous for use in various applications, clinical settings, and epidemiological investigations. Numerous high-quality clinical studies have underscored the significance of the TyG index in diverse medical conditions. This review provides a synthesis of the association between the TyG index and diseases such as diabetes, cardiovascular diseases, cerebrovascular diseases, fatty liver, kidney diseases, and reproductive system diseases. Furthermore, the TyG index has exhibited predictive capabilities for identifying IR in children and adolescents. Through a systematic review of pertinent clinical trials, this paper elucidates the correlation between the TyG index and various diseases. The findings presented herein suggest that the TyG index holds promise as a valuable and practical indicator for different medical conditions, prompting a reevaluation of conventional disease risk assessment paradigms and highlighting the intricate interplay of metabolic parameters with diverse diseases. By leveraging insights from the TyG index, tailored disease risk management strategies can be developed to offer a fresh perspective and guidance for clinical interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, PR China.
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, PR China. Electronic address: lfm565@sohu.com.
Zitieren
APA
Sun, Y., Ji, H., Sun, W., An, X., & Lian, F. (2025). Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases. European Journal of Internal Medicine, 131, 3-14. https://doi.org/10.1016/j.ejim.2024.08.026
Vancouver
Sun Y, Ji H, Sun W, An X, Lian F. Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases. European Journal of Internal Medicine. 2025;131:3-14. doi:10.1016/j.ejim.2024.08.026
BibTeX
@article{Sun2025,
author = {Sun, Yuting and Ji, Hangyu and Sun, Wenjie and An, Xuedong and Lian, Fengmei},
title = {Triglyceride glucose (TyG) index: A promising biomarker for diagnosis and treatment of different diseases},
journal = {European Journal of Internal Medicine},
year = {2025},
volume = {131},
pages = {3--14},
doi = {10.1016/j.ejim.2024.08.026}
}
EUVIMED